PLEKHA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.886800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.153000E-01
Normal-vs-Stage2
4.034200E-01
Normal-vs-Stage3
3.217400E-01
Normal-vs-Stage4
4.049400E-01
Stage1-vs-Stage2
1.096230E-01
Stage1-vs-Stage3
8.719600E-01
Stage1-vs-Stage4
6.001900E-02
Stage2-vs-Stage3
2.265200E-01
Stage2-vs-Stage4
9.987800E-01
Stage3-vs-Stage4
1.014590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.864600E-01
Normal-vs-AfricanAmerican
4.236600E-01
Normal-vs-Asian
3.644200E-01
Caucasian-vs-AfricanAmerican
6.331400E-01
Caucasian-vs-Asian
5.883800E-01
AfricanAmerican-vs-Asian
4.276800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.877800E-01
Normal-vs-Female
3.909600E-01
Male-vs-Female
8.849800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.289200E-01
Normal-vs-Age(41-60Yrs)
4.196400E-01
Normal-vs-Age(61-80Yrs)
3.725000E-01
Normal-vs-Age(81-100Yrs)
3.681600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.853000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.858400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.758600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.181500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.684830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.988200E-01
Normal-vs-Daily Drinker
3.516600E-01
Normal-vs-Weekly Drinker
3.543600E-01
Normal-vs-Occasional Drinker
3.809600E-01
Normal-vs-Social Drinker
3.877400E-01
Non Drinker-vs-Daily Drinker
2.940600E-01
Non Drinker-vs-Weekly Drinker
3.446000E-01
Non Drinker-vs-Occasional Drinker
7.278200E-01
Non Drinker-vs-Social Drinker
8.591000E-01
Daily Drinker-vs-Weekly Drinker
9.434200E-01
Daily Drinker-vs-Occasional Drinker
4.188400E-01
Daily Drinker-vs-Social Drinker
3.572600E-01
Weekly Drinker-vs-Occasional Drinker
5.046200E-01
Weekly Drinker-vs-Social Drinker
4.357600E-01
Occasional Drinker-vs-Social Drinker
8.851200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.938200E-01
Normal-vs-Grade 2
1.474400E-02
Normal-vs-Grade 3
3.251500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.233360E-01
Grade 1-vs-Grade 3
7.483700E-02
Grade 1-vs-Grade 4
2.938200E-01
Grade 2-vs-Grade 3
4.926000E-01
Grade 2-vs-Grade 4
1.474400E-02
Grade 3-vs-Grade 4
3.251500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.858000E-01
Normal-vs-NonDiabetic
3.774000E-01
Diabetic-vs-NonDiabetic
7.640600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.603600E-01
Normal-vs-NoPancreatitis
3.841400E-01
Pancreatitis-vs-NoPancreatitis
3.628400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.582400E-01
Normal-vs-N1
4.072800E-01
N0-vs-N1
3.759500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.644000E-01
Normal-vs-TP53-NonMutant
3.412600E-01
TP53-Mutant-vs-TP53-NonMutant
4.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
